Chen Qing Selected Research

Chen Qing Research Topics

Disease

23	Neoplasms (Cancer) 05/2022 - 09/2004
3	Adenocarcinoma of Lung 01/2019 - 02/2008
3	Neoplasm Metastasis (Metastasis) 11/2017 - 08/2013
3	Leukemia 07/2016 - 05/2003
2	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 11/2017
2	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2008
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2013 - 01/2011
1	Carcinoma (Carcinomatosis) 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Wounds and Injuries (Trauma) 02/2021
1	Hypersensitivity (Allergy) 02/2021
1	Ischemic Stroke 01/2021
1	Colonic Neoplasms (Colon Cancer) 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 09/2018
1	Circulating Neoplastic Cells 11/2017
1	Inflammation (Inflammations) 12/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2016
1	Sarcoma (Soft Tissue Sarcoma) 07/2016
1	Colorectal Neoplasms (Colorectal Cancer) 03/2016
1	Hypoxia (Hypoxemia) 04/2015
1	Acidosis 11/2013
1	Ischemia 11/2013
1	Familial primary gastric lymphoma 09/2012
1	Acute Lung Injury 06/2011
1	Acute Promyelocytic Leukemia 01/2011
1	Lymphoma (Lymphomas) 12/2008
1	Lymphoid Leukemia 05/2008

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 05/2022 - 01/2011
4	GibberellinsIBA 12/2020 - 09/2009
4	13-chlorine-3,15-dioxy-gibberellic acid methyl esterIBA 12/2020 - 02/2012
3	Arsenic Trioxide (Trisenox)FDA Link 12/2013 - 12/2008
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2022 - 09/2004
2	trioctyl phosphine oxide (TOPO)IBA 05/2022 - 09/2004
2	linaloolIBA 12/2020 - 01/2017
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2020 - 01/2017
2	AcidsIBA 01/2019 - 11/2013
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 09/2004
2	salvicineIBA 08/2013 - 05/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 02/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022
1	ProdrugsIBA 05/2022
1	Cisplatin (Platino)FDA LinkGeneric 05/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2022
1	rubitecanIBA 05/2022
1	CamptothecinIBA 05/2022
1	Caspase 3 (Caspase-3)IBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 12/2020
1	Interleukin-2 (IL2)IBA 12/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2020
1	AntibodiesIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Tight Junction ProteinsIBA 10/2020
1	EstersIBA 01/2019
1	Sirtuin 1IBA 09/2018
1	Circulating Tumor DNAIBA 11/2017
1	Cell-Free Nucleic AcidsIBA 11/2017
1	TransferasesIBA 01/2017
1	linalyl acetateIBA 01/2017
1	ParaffinIBA 01/2017
1	Volatile Oils (Essential Oils)IBA 01/2017
1	NucleotidesIBA 12/2016
1	InflammasomesIBA 12/2016
1	SmokeIBA 12/2016
1	26-deoxyacteinIBA 07/2016
1	acteinIBA 07/2016
1	bisleuconothine AIBA 03/2016
1	CateninsIBA 03/2016
1	CaspasesIBA 03/2016
1	AlkaloidsIBA 03/2016
1	scutellarinIBA 04/2015
1	Messenger RNA (mRNA)IBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Nifedipine (Adalat)FDA LinkGeneric 11/2013
1	IntegrinsIBA 08/2013
1	Factor VIII (Coagulation Factor VIII)IBA 02/2012
1	(23R,24S)- 16,23- 16,24- diepoxy- 9,19- cyclolanostan- 3beta,15alpha,25- triolIBA 01/2012
1	LipopolysaccharidesIBA 06/2011
1	CytokinesIBA 06/2011
1	Interleukin-8 (Interleukin 8)IBA 06/2011
1	EndotoxinsIBA 06/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	KetonesIBA 09/2009
1	asclepinIBA 04/2009
1	Carboplatin (JM8)FDA LinkGeneric 05/2008
1	BromidesIBA 02/2008
1	LactonesIBA 02/2008

Therapy/Procedure

5	Therapeutics 07/2021 - 09/2012
1	Oral Administration 05/2022
1	Intravenous Injections 05/2022
1	Drug Therapy (Chemotherapy) 07/2021
1	Radiotherapy 07/2021
1	Sutures (Suture) 02/2021
1	Rhytidoplasty (Facelift) 02/2021
1	Thrombectomy 01/2021
1	Transplantation 01/2017